Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-03-14 @ 3:38 AM
Study NCT ID:
NCT03302234
Status:
COMPLETED
Last Update Posted:
2023-09-26
First Post:
2017-09-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-26
First Submit QC Date:
None
Study First Post Date:
2017-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-12
Results First Submit QC Date:
None
Results First Post Date:
2021-09-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-25
Last Update Post Date:
2023-09-26
Last Update Post Date Type:
ACTUAL